|
|
| | 2,6-Pyridinedicarboxamide, N2-[(1R)-1,2-dimethylpropyl]-4-(1-methyl-1H-indol-2-yl)-N6-[2-(2-pyridinyl)ethyl]- Basic information |
| | 2,6-Pyridinedicarboxamide, N2-[(1R)-1,2-dimethylpropyl]-4-(1-methyl-1H-indol-2-yl)-N6-[2-(2-pyridinyl)ethyl]- Chemical Properties |
| Boiling point | 699.6±55.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | pka | 13.25±0.46(Predicted) | | form | Solid | | color | White to light yellow |
| | 2,6-Pyridinedicarboxamide, N2-[(1R)-1,2-dimethylpropyl]-4-(1-methyl-1H-indol-2-yl)-N6-[2-(2-pyridinyl)ethyl]- Usage And Synthesis |
| Uses | STAT6-IN-2 (Compound R-84) is a STAT6 inhibitor that can inhibit the tyrosine phosphorylation of STAT6. STAT6-IN-2 can also inhibit the secretion of eotaxin-3. STAT6-IN-2 can be used in the research of immune diseases and allergic inflammatory diseases such as asthma[1]. | | References | [1] Zhou L, et.al. STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells. Bioorg Med Chem. 2012 Jan 15;20(2):750-8. DOI:10.1016/j.bmc.2011.12.006 |
| | 2,6-Pyridinedicarboxamide, N2-[(1R)-1,2-dimethylpropyl]-4-(1-methyl-1H-indol-2-yl)-N6-[2-(2-pyridinyl)ethyl]- Preparation Products And Raw materials |
|